These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34168120)

  • 1. LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of ERK signaling in pancreatic cancer.
    Xu J; Wang J; He Z; Chen P; Jiang X; Chen Y; Liu X; Jiang J
    Cell Death Dis; 2021 Jun; 12(7):648. PubMed ID: 34168120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA CERS6-AS1 Accelerates the Proliferation and Migration of Pancreatic Cancer Cells by Sequestering MicroRNA-15a-5p and MicroRNA-6838-5p and Modulating HMGA1.
    Shen R; Wang X; Wang S; Zhu D; Li M
    Pancreas; 2021 Apr; 50(4):617-624. PubMed ID: 33939677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CERS6-AS1 promotes cell proliferation and represses cell apoptosis in pancreatic cancer via miR-195-5p/WIPI2 axis.
    Gao KF; Zhao YF; Liao WJ; Xu GL; Zhang JD
    Kaohsiung J Med Sci; 2022 Jun; 38(6):542-553. PubMed ID: 35199935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA RGMB-AS1 facilitates pancreatic cancer cell proliferation and migration but inhibits cell apoptosis via miR-574-3p/PIM3 axis.
    Song W; Shi C
    Am J Physiol Gastrointest Liver Physiol; 2021 Nov; 321(5):G477-G488. PubMed ID: 34468207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long coding RNA AFAP1-AS1 promotes tumor cell growth and invasion in pancreatic cancer through upregulating the IGF1R oncogene via sequestration of miR-133a.
    Chen B; Li Q; Zhou Y; Wang X; Zhang Q; Wang Y; Zhuang H; Jiang X; Xiong W
    Cell Cycle; 2018; 17(16):1949-1966. PubMed ID: 30300116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA CERS6-AS1, sponging miR-6838-5p, promotes proliferation and invasion in cervical carcinoma cells by upregulating FOXP2.
    Yan K; Hu C; Liu C; Chu G; Wang X; Ma S; Li L
    Histol Histopathol; 2023 Jul; 38(7):823-835. PubMed ID: 36444938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
    Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression.
    Yan J; Jia Y; Chen H; Chen W; Zhou X
    J Exp Clin Cancer Res; 2019 Sep; 38(1):390. PubMed ID: 31488171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CERS6-AS1 contributes to the malignant phenotypes of colorectal cancer cells by interacting with miR-15b-5p to regulate SPTBN2.
    Zhao SY; Wang Z; Wu XB; Zhang S; Chen Q; Wang DD; Tan QF
    Kaohsiung J Med Sci; 2022 May; 38(5):403-414. PubMed ID: 35146902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway.
    Wang H; Niu X; Jiang H; Mao F; Zhong B; Jiang X; Fu G
    Aging (Albany NY); 2020 Aug; 12(16):16021-16034. PubMed ID: 32756011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA CERS6-AS1 Is a Tumor Promoter in Cervical Cancer by Sponging miR-195-5p.
    Xiong S; Song H
    Ann Clin Lab Sci; 2023 Jan; 53(1):30-41. PubMed ID: 36889776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceramide synthase 6 antisense RNA 1 contributes to the progression of breast cancer by sponging miR-16-5p to upregulate ubiquitin-conjugating enzyme E2C.
    Pan W; Chen KJ; Huang YC
    Anticancer Drugs; 2022 Oct; 33(9):913-922. PubMed ID: 36136991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA CERS6-AS1 as ceRNA promote cell proliferation of breast cancer by sponging miR-125a-5p to upregulate BAP1 expression.
    Yan L; Li K; Feng Z; Zhang Y; Han R; Ma J; Zhang J; Wu X; Liu H; Jiang Y; Zhang Y; Zhu Y
    Mol Carcinog; 2020 Oct; 59(10):1199-1208. PubMed ID: 32808708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNAH17-AS1 promotes pancreatic carcinoma by increasing PPME1 expression
    Xu T; Lei T; Li SQ; Mai EH; Ding FH; Niu B
    World J Gastroenterol; 2020 Apr; 26(15):1745-1757. PubMed ID: 32351291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA PCED1B-AS1 mediates miR-3681-3p/MAP2K7 axis to promote metastasis, invasion and EMT in gastric cancer.
    Cao J; Yang Y; Duan B; Zhang H; Xu Q; Han J; Lu B
    Biol Direct; 2024 May; 19(1):34. PubMed ID: 38698487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA KTN1-AS1 promotes progression in pancreatic cancer through regulating microRNA-23b-3p/high-mobility group box 2 axis.
    Zhang ZB; Liu N
    Aging (Albany NY); 2021 Aug; 13(16):20820-20835. PubMed ID: 34461605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA ZEB1-AS1 promotes pancreatic cancer progression by regulating miR-505-3p/TRIB2 axis.
    Wei G; Lu T; Shen J; Wang J
    Biochem Biophys Res Commun; 2020 Aug; 528(4):644-649. PubMed ID: 32513531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4.
    Hui B; Ji H; Xu Y; Wang J; Ma Z; Zhang C; Wang K; Zhou Y
    Cell Death Dis; 2019 Feb; 10(3):207. PubMed ID: 30814490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.